;
Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • Anacor sales and marketing update

    Anacor Pharmaceuticals Inc. (NASDAQ:ANAC), Palo Alto, Calif. Business: Infectious Anacor said the Sandoz Inc. generics unit of Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Switzerland) launched Kerydin tavaborole in the U.S.…

    Published on 9/29/2014
  • Biotie, Lundbeck sales and marketing update

    Biotie Therapies Corp. (HSE:BTH1V), Turku, Finland H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Business: Neurology Biotie said Lundbeck launched Selincro nalmefene in France to reduce alcohol consumption in adults …

    Published on 9/29/2014
  • Clinigen Group sales and marketing update

    Clinigen Group plc (LSE:CLIN), Burton-on-Trent, U.K. Business: Infectious Clinigen launched Vibativ telavancin in Europe to treat hospital-acquired (nosocomial) pneumonia, including ventilator-associated pneumonia, …

    Published on 9/29/2014
  • Mobidiag sales and marketing update

    Mobidiag Ltd., Helsinki, Finland Business: Diagnostic Mobidiag launched Amplidiag Bacterial GE in Europe to screen for gastroenteritis-causing bacteria from stool samples. The PCR-based diagnostic has CE Mark approval.

    Published on 9/29/2014
  • Novartis, Omnicare sales and marketing update

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Omnicare Inc. (NYSE:OCR), Cincinnati, Ohio Business: Cancer Omnicare's Advanced Care Scripts (ACS) division was selected to be part of a limited starter-dose …

    Published on 9/29/2014
  • Roche sales and marketing update

    Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Diagnostic Roche launched its Elecsys Anti-Mullerian Hormone (AMH) blood test in "most" countries that recognize CE Mark approval to assess a woman's ovarian …

    Published on 9/29/2014
  • Vela Diagnostics sales and marketing update

    Vela Diagnostics, Singapore Business: Diagnostic Vela launched the Sentosa SQ Melanoma Panel to detect melanoma. The automated pipetting system for nucleic acid extraction and PCR setup simultaneously detects 127 hot …

    Published on 9/29/2014
  • Biocartis sales and marketing update

    Biocartis S.A., Lausanne, Switzerland Business: Diagnostic Biocartis launched its Idylla molecular diagnostics platform and Idylla BRAF Mutation Test in countries that accept CE Mark. Idylla is an automated, real-time …

    Published on 9/22/2014
  • Daiichi Sankyo, Mitsubishi Tanabe Pharma sales and marketing update

    Daiichi Sankyo Co. Ltd. (Tokyo:4568), Tokyo, Japan Mitsubishi Tanabe Pharma Corp. (Tokyo:4508), Osaka, Japan Business: Endocrine/Metabolic Mitsubishi and Daiichi launched Canaglu canagliflozin in Japan to treat Type II …

    Published on 9/22/2014
  • Kyowa Hakko Kirin, Leo Pharma sales and marketing update

    Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151), Tokyo, Japan Leo Pharma A/S, Ballerup, Denmark Business: Dermatology Kyowa launched Dovobet Ointment calcipotriene/betamethasone dipropionate in Japan to treat psoriasis vulgaris…

    Published on 9/22/2014
  • Panagene sales and marketing update

    Panagene Inc., Daejeon, South Korea Business: Diagnostic Panagene launched four products integrated with the company's C-melting technology, which detects mutations from circulating tumor DNA in blood. According to …

    Published on 9/22/2014
  • AstraZeneca sales and marketing update

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Endocrine/Metabolic, Drug delivery AstraZeneca launched Bydureon Pen for self-injection of once-weekly Bydureon exenatide in the U.S. to treat Type II …

    Published on 9/15/2014
  • Biotie, Lundbeck sales and marketing update

    Biotie Therapies Corp. (HSE:BTH1V), Turku, Finland H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Business: Neurology Biotie said partner Lundbeck launched Selincro nalmefene in Germany to reduce alcohol consumption in…

    Published on 9/15/2014
  • Boehringer Ingelheim, Eli Lilly sales and marketing update

    Boehringer Ingelheim GmbH, Ingelheim, Germany Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Endocrine/Metabolic The pharmas launched Jardiance empagliflozin tablets in the U.S. to treat Type II diabetes. …

    Published on 9/15/2014
  • Chugai sales and marketing update

    Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Business: Cancer Chugai launched Alecensa alectinib in Japan to treat unresectable, recurrent or advanced anaplastic lymphoma kinase (ALK)-positive non-small …

    Published on 9/15/2014
  • Ipsen sales and marketing update

    Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulgne-Billancourt, France Business: Endocrine/Metabolic Ipsen said a second batch of Increlex mecasermin will be available this month to treat pediatric patients with severe …

    Published on 9/15/2014
  • LabCorp sales and marketing update

    Laboratory Corp. of America Holdings (NYSE:LH), Burlington, N.C. Business: Diagnostic LabCorp launched the informaSeq Prenatal Test to assess risk for multiple fetal chromosomal aneuploidies in maternal cell-free DNA (…

    Published on 9/15/2014
  • Pragma Pharmaceuticals sales and marketing update

    Pragma Pharmaceuticals LLC, Locust Valley, N.Y. Business: Infectious Pragma re-launched Moxatag, a once-daily, extended-release formulation of amoxicillin. The product has been approved in the U.S. since 2008 to treat …

    Published on 9/15/2014
  • Roche sales and marketing update

    Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Diagnostic Roche launched its next-generation real-time PCR cobas 6800 and 8800 systems in markets accepting the CE Mark, including Europe, Latin America, the …

    Published on 9/15/2014
  • Teva sales and marketing update

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Infectious Teva launched a generic version of 0.5 and 1 mg Baraclude entecavir in the U.S. Teva said it will have 180 days of generic market…

    Published on 9/15/2014
  • Theratechnologies, Merck KGaA sales and marketing update

    Theratechnologies Inc. (TSX:TH), Montreal, Quebec Merck KGaA (Xetra:MRK), Darmstadt, Germany Business: Endocrine/Metabolic Theratechnologies said it sent a first shipment of 1 mg Egrifta tesamorelin to its U.S. …

    Published on 9/15/2014
  • Theravance Biopharma sales and marketing update

    Theravance Biopharma Inc. (NASDAQ:TBPH), South San Francisco, Calif. Business: Infectious Theravance said it has launched Vibativ telavancin in a limited number of geographic territories in the U.S during the past year…

    Published on 9/15/2014
  • Lundbeck sales and marketing update

    H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Business: Cardiovascular H. Lundbeck launched Northera droxidopa in the U.S. to treat symptomatic neurogenic orthostatic hypotension (NOH). The wholesale acquisition cost …

    Published on 9/8/2014
  • MDxHealth sales and marketing update

    MDxHealth S.A. (Euronext:MDXH), Liege, Belgium Business: Diagnostic MDxHealth said U.S. healthcare providers Consilium LLC and the Ancillary Care Services (ACS) of American CareSource Holdings Inc. will cover MDxHealth'…

    Published on 9/8/2014
  • Ono Pharmaceutical sales and marketing update

    Ono Pharmaceutical Co. Ltd. (Tokyo:4528), Osaka, Japan Business: Cancer Ono launched Opdivo nivolumab in Japan to treat unresectable melanoma. The Japanese National Health Insurance (NHI) list price is Y728,849 ($6,996.…

    Published on 9/8/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993